Executive Summary
This Material Events Monitor digest covers 50 filings from July 27, 2026, revealing a market dominated by aggressive M&A and strategic capital allocation, particularly in the biotech and energy sectors.
The most significant development is argenx's $2.2 billion acquisition of Forte Biosciences, signaling a major bet on the autoimmune pipeline, while Lattice Semiconductor's acquisition of AMI targets data center AI growth. A clear sector theme is the wave of auditor changes tied to the AES Corp. merger, with three subsidiaries switching from EY to KPMG, a procedural but notable event. Several companies are aggressively refinancing to lower costs and extend maturities, including Somnigroup ($2.9B) and Target Hospitality ($660M), while others like Glucotrack and Ocean Power Technologies are resorting to dilutive debt-to-equity conversions and ATM offerings, highlighting a bifurcation in financial health. Insider activity is sparse, but the CEO succession at Cracker Barrel and the new CEO appointment at Power Solutions International are key leadership events to watch. Overall, the market is showing strong conviction in high-growth areas through M&A, while some smaller caps face liquidity and governance challenges.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from July 24, 2026.
Investment Signals (12)
- Forte Biosciences (FBRX) (BULLISH)▲
Acquired by argenx for $77/share (86% premium), with FB102 showing positive Phase 1b data in vitiligo and celiac disease. This validates the platform and provides a clear exit for shareholders.
- Lattice Semiconductor (LSCC) (BULLISH)▲
Completed acquisition of AMI, expected to be accretive to gross margin, FCF, and non-GAAP EPS, supporting a trajectory toward $1B+ revenue run-rate by end of 2026.
- Talos Energy (TALO) (BULLISH)▲
Acquired 50% working interest in Block 29 offshore Mexico (200+ MMBoe resource) with a contingent $30M payment at FID, signaling a high-impact, low-capex entry into a proven basin.
- Target Hospitality (TH) (BULLISH)▲
Closed a new $660M ABL facility (up from $175M), reducing borrowing costs by up to 250 bps and extending maturity to 2031, with an active pipeline of 20,000+ beds.
- Zeta Global (ZETA) (BULLISH)▲
Closed a $1B credit facility (up from $550M) with lower spreads, providing significant dry powder for M&A and share repurchases.
- Somnigroup International (SGI) (BULLISH)▲
Amended $2.9B credit facilities, adding $700M liquidity and reducing annual interest expense by ~$5M, enhancing financial flexibility.
- Glucotrack (GCTK) (BEARISH)▲
Entered into a dilutive debt-to-equity exchange with a variable price tied to Nasdaq closing prices, reflecting ongoing financial distress and shareholder dilution.
- Ocean Power Technologies (OPTT) (BEARISH)▲
Filed for a $20M ATM offering, creating potential dilution risk for existing shareholders despite providing flexible capital.
- PetVivo Holdings (PVVO) (BEARISH)▲
Auditor resigned with a going concern qualification in the FY2026 audit report, signaling severe financial distress.
- Power Solutions International (PSIX) (BULLISH)▲
Appointed Richard Hu (ex-BorgWarner) as CEO, a strong hire from a top-tier industrial company, signaling a strategic pivot toward operational excellence.
- Gossamer Bio (GOSS) (MIXED)▲
NDA submission for seralutinib planned for September 2026, with FDA characterizing statistical significance as a review issue, not a filing issue. However, only $57M cash may be insufficient to fund operations through a potential Q3 2027 approval.
- Kustom Entertainment (KUST) (BULLISH)▲
Amended divestiture agreement with Cycurion, increasing valuation to $6.1M and securing a 12% cumulative dividend on preferred stock, completing its transformation to a pure-play live entertainment company.
Risk Flags (10)
- Glucotrack (GCTK) / Dilution [HIGH RISK]▼
Debt-to-equity conversion at a variable price (lower of prior day's close or 5-day average) with no new cash proceeds, creating continuous dilution for existing shareholders.
- PetVivo Holdings (PVVO) / Going Concern [HIGH RISK]▼
Auditor resigned after issuing a going concern opinion for FY2026, indicating a high probability of bankruptcy or restructuring.
- Generation Income Properties (GIPR) / Nasdaq Compliance [HIGH RISK]▼
Debt conversion brought equity above $5M, but Nasdaq will continue monitoring; failure at next periodic report could lead to delisting.
- Gossamer Bio (GOSS) / Cash Runway [HIGH RISK]▼
Only $57M in cash as of June 30, 2026, which may be insufficient to fund operations through a potential Q3 2027 FDA approval, necessitating dilutive financing.
- ▼
Former auditor declined re-election due to strategic shift away from the sector, and a material weakness in internal controls over income taxes was identified.
- Onfolio Holdings (ONFO) / Failed M&A [MEDIUM RISK]▼
LOI to acquire Paramount Helium terminated after just 14 days, indicating poor deal execution or due diligence issues.
- One World Products (OWPC) / Governance [MEDIUM RISK]▼
CEO removed a board member and reduced board size from seven to five, a significant governance change that could signal instability.
- AES Corp. (AES) / Internal Control Weakness↓ [MEDIUM RISK]▼
EY's FY2024 audit report contained an adverse opinion on internal controls due to a material weakness in the AES Brasil disposition process, a red flag for financial reporting quality.
- Co-Diagnostics (CODX) / Dilution Risk↓ [MEDIUM RISK]▼
Removed the fixed dollar limit on its ATM offering, allowing unlimited sales of common stock under its shelf registration, increasing dilution risk.
- Bed Bath & Beyond (BBBY) / Undisclosed Deal [MEDIUM RISK]▼
Entered into a merger agreement to acquire F9 Brands without disclosing the purchase price, creating uncertainty about the financial impact and potential value destruction.
Opportunities (10)
- Forte Biosciences (FBRX) / M&A Arbitrage (OPPORTUNITY)◆
The $77/share cash acquisition by argenx offers a near-term arbitrage opportunity with a high probability of closing in Q3 2026, given both boards' approval and cash funding.
- Lattice Semiconductor (LSCC) / Post-Merger Growth (OPPORTUNITY)◆
The AMI acquisition is expected to be accretive and supports a $1B+ revenue run-rate. Q2 2026 earnings on August 4 will provide initial details on AMI's contribution.
- Talos Energy (TALO) / Mexico Discovery (OPPORTUNITY)◆
The 50% stake in Block 29 (200+ MMBoe) with a path to FID in 2027 offers significant upside if the Polok and Chinwol discoveries are developed.
- Target Hospitality (TH) / Refinancing Catalyst (OPPORTUNITY)◆
The new $660M ABL facility dramatically improves liquidity and reduces interest costs, positioning the company to capitalize on its 20,000+ bed pipeline.
- Zeta Global (ZETA) / Capital for Growth (OPPORTUNITY)◆
The $1B credit facility (with $750M undrawn) provides ample firepower for accretive M&A and share repurchases, a potential catalyst for EPS growth.
- Gossamer Bio (GOSS) / Binary Catalyst (OPPORTUNITY)◆
NDA submission for seralutinib in September 2026 is a high-impact event. If approved, the reacquired worldwide rights (without upfront cash) could be transformative.
- Power Solutions International (PSIX) / New CEO Catalyst (OPPORTUNITY)◆
The appointment of a seasoned executive from BorgWarner could signal a strategic shift toward higher-margin, technology-driven products, potentially re-rating the stock.
- Somnigroup International (SGI) / Interest Savings (OPPORTUNITY)◆
The $5M annual interest expense reduction from the refinancing directly boosts net income, a clear near-term earnings catalyst.
- Novelis Inc. / Short-Term Financing↓ (OPPORTUNITY)◆
The $500M unsecured term loan at SOFR + 1.00% is a low-cost, flexible financing for general corporate purposes, signaling strong credit access.
- Venu Holding Corp (VENU) / Venue Opening↓ (OPPORTUNITY)◆
The Regent Bank Amphitheater (12,500 seats) is targeted to open in Fall 2026, with Legends Global managing operations, a potential revenue catalyst.
Sector Themes (6)
- Biotech M&A Surge◆
The argenx/Forte deal ($2.2B, 86% premium) and Gossamer's NDA filing highlight a robust appetite for late-stage autoimmune assets. This is a positive signal for the sector, suggesting large pharma is willing to pay up for de-risked, first-in-class therapies.
- Energy Sector Re-capitalization◆
Talos Energy's farm-in and International Battery Metals' interim CEO appointment reflect a theme of capital deployment in energy assets. Talos's move into Mexico's deepwater is a high-risk, high-reward play, while IBAT's leadership change suggests a strategic pivot.
- Auditor Exodus at AES Corp.◆
The coordinated dismissal of EY and engagement of KPMG across AES Corp. and three subsidiaries (Dayton Power & Light, IPALCO, DPL) is a massive, synchronized auditor change. While procedural, it creates a temporary risk of reporting delays or inconsistencies.
- Liquidity Bifurcation◆
A clear divide is emerging between companies with strong access to capital (Zeta, Target, Somnigroup) and those resorting to dilutive financing (Glucotrack, Ocean Power, Co-Diagnostics). This suggests investors should favor companies with strong balance sheets and avoid those with repeated ATM or debt-to-equity conversions.
- Leadership Churn in Industrials◆
Multiple companies (PSIX, Cracker Barrel, Cadiz, Swarmer) are appointing new CEOs or C-suite executives, signaling a period of strategic repositioning. The quality of hires (e.g., ex-BorgWarner at PSIX, ex-Bloomin' Brands at Cracker Barrel) suggests a focus on operational turnaround.
- SPAC Activity Continues◆
Translational Development Acquisition Corp. (TDAC) is progressing toward a business combination with ProLogium, a battery company. This is a reminder that SPACs remain a viable path to public markets for high-growth private companies, despite the broader slowdown.
Watch List (8)
- Lattice Semiconductor (LSCC)👁
Q2 2026 earnings on August 4, 2026, will provide the first detailed look at AMI's financials and the combined company's revenue run-rate. [August 4, 2026]
- Gossamer Bio (GOSS)👁
NDA submission for seralutinib in September 2026. Watch for any FDA acceptance or rejection, and any capital raise announcements given the $57M cash position. [September 2026]
- Forte Biosciences (FBRX)👁
Merger with argenx expected to close in Q3 2026. Monitor for shareholder vote and regulatory approvals. [Q3 2026]
- Cracker Barrel (CBRL)👁
CEO transition to David Deno effective August 10, 2026. Watch for any strategic announcements or changes in financial guidance. [August 10, 2026]
- Power Solutions International (PSIX)👁
New CEO Richard Hu takes over on August 17, 2026. Monitor for any strategic shifts, cost-cutting, or new business initiatives. [August 17, 2026]
- Generation Income Properties (GIPR)👁
Nasdaq will continue to monitor stockholders' equity compliance. Failure to evidence compliance at the next periodic report could lead to delisting. [Ongoing]
- Talos Energy (TALO)👁
Farm-in agreement for Block 29 Mexico is subject to SENER and anti-trust approval. Watch for regulatory clearance and any updates on the FID timeline. [Ongoing]
- Bed Bath & Beyond (BBBY)👁
The acquisition of F9 Brands is a major event. Watch for disclosure of the purchase price and any integration plans. [Ongoing]
Filing Analyses
(50)
27-07-2026
argenx (ARGX) will acquire Forte Biosciences (FBRX) for $77 per share in cash, representing a total equity value of approximately $2.2 billion and an 86% premium to Forte's VWAP since its positive Phase 1b vitiligo data on July 9, 2026. The acquisition adds FB102, a first-in-class anti-CD122 antibody with clinical proof-of-concept in vitiligo and celiac disease, to argenx's immunology pipeline. The transaction is expected to close in Q3 2026, funded entirely from cash on hand, and has been approved by both boards.
- · FB102 Phase 1b data in vitiligo showed statistically significant treatment benefit.
- · Positive FB102 Phase 1b data in celiac disease was shared last year; Phase 2 data expected in second half of 2026.
- · FB102 has potential to address alopecia areata and additional autoimmune diseases.
- · The tender offer requires at least a majority of outstanding shares tendered and HSR Act waiting period expiration.
- · Transaction is not subject to a financing condition.
- · argenx will host an investor conference call at 8:00 a.m. ET on July 27, 2026.
27-07-2026
Profusa, Inc. announced the signing of a non-binding term sheet to acquire a privately held commercial-stage diagnostics company (the 'Dx Company') with estimated 2025 net revenues of approximately $111 million. Concurrently, Jack Stover was appointed Executive Chairman and CEO, replacing Ben Hwang who became President, and Liviu Goldenberg was appointed as an independent director. The transaction is expected to close with Profusa issuing 19.99% of its common stock and non-voting convertible preferred stock as consideration, along with approximately $7 million in convertible note financing.
- · The Dx Company is a commercial-stage health diagnostics and toxicology testing company with CLIA-certified and CAP/CLIA accredited national medical laboratories.
- · The Dx Company serves addiction treatment, pain management, and behavioral health providers.
- · Profusa's outstanding convertible notes and obligations are expected to be exchanged for Preferred Stock.
- · The convertible note financing is subordinated to existing bank debt and has a 12-month term.
- · Existing investors in Profusa may provide all or portions of the $7 million financing.
27-07-2026
SemiLEDs Corp announced a change in its independent registered public accounting firm. YCM CPA INC. engagement expired on July 27, 2026, and the audit committee engaged DLEE Accountancy, Inc. as the new auditor. There were no disagreements or reportable events with the former auditor.
- · No disagreements or reportable events occurred with YCM during the most recent fiscal year and through the expiration date.
- · The company has not consulted DLEE on any accounting, auditing, or financial reporting issues prior to engagement.
27-07-2026
Papaya Growth Opportunity Corp. I disclosed that its former auditor, Citrin Cooperman & Company, LLP, declined to stand for re-election effective July 22, 2026, due to a strategic shift away from the company's sector. The audit committee has appointed Malone Bailey, LLP as the new independent registered public accounting firm. The change was not due to any disagreements on accounting principles, but the company had previously identified a material weakness in internal control over financial reporting related to income taxes.
- · The former auditor's reports for fiscal years ended December 31, 2024 and 2023 included an explanatory paragraph about substantial doubt regarding the company's ability to continue as a going concern.
- · A material weakness in internal control over financial reporting related to proper recording of income taxes was identified in the 2023 annual report and quarterly reports for March 31, 2025, June 30, 2025, and September 30, 2025.
- · No disagreements or reportable events occurred between the company and the former auditor during the relevant periods, aside from the material weakness noted.
27-07-2026
On July 21, 2026, Onfolio Holdings Inc. and Paramount Helium, LLC mutually terminated their Binding Letter of Intent to acquire Paramount, originally signed on July 7, 2026. The termination was by mutual consent with no penalties or further financial obligations for either party. The deal fell through just two weeks after the LOI was signed, indicating a very short-lived acquisition attempt.
- · The LOI was signed on July 7, 2026, and terminated just 14 days later on July 21, 2026.
- · Confidentiality obligations under a Mutual Non-Disclosure Agreement dated June 10, 2026 survive the termination.
- · No termination penalties or financial obligations were incurred by either party; each bears its own costs.
- · A press release announcing the termination was issued on July 22, 2026.
27-07-2026
Balchem Corporation entered into Amendment No. 1 to its Amended and Restated Credit Agreement, effective July 24, 2026, which amends the existing credit facility, adds a new foreign borrower (Balchem B.V.), and replaces a departing lender (KeyBank National Association). The amendment also reallocates commitments among lenders and includes new lenders. No financial figures or performance metrics are disclosed in this filing.
- · The amendment adds Balchem B.V. (Netherlands) as a new foreign borrower under the credit agreement.
- · KeyBank National Association is departing as a lender; its loans are repaid in full and its commitments terminated.
- · New lenders join the facility, and commitments are reallocated among all lenders.
- · The amendment modifies several schedules and exhibits of the existing credit agreement (Schedules 2.01A, 2.01B, 6.09, 6.13, 6.17, 6.20-1, 6.20-2, 8.02, 11.02 and exhibits).
27-07-2026
Swarmer, Inc. announced a promotion and realignment of its executive leadership team. Garrett Kasper was promoted to Chief Communications Officer, Serhii Kupriienko will lead a new innovation unit called Swarmer Labs, and CEO Alexander Fink's oversight was expanded to include HR, finance, and operations. The changes aim to balance short-term delivery with long-term innovation as the company scales.
- · Swarmer's technology has been deployed in combat operations in Ukraine since April 2024 and has completed more than 100,000 combat missions.
- · Garrett Kasper retired from the Navy Reserve on June 1, 2026, as a highly decorated captain.
- · Swarmer maintains operations and teams in Ukraine, Poland, and Estonia.
- · The company is not a drone manufacturer and operates at the intelligence layer, developing autonomy, coordination, and decision-making software.
27-07-2026
SPX Technologies announced the appointment of Brian Deck as a new independent member of its Board of Directors, effective July 27, 2026. Mr. Deck, who is the CEO of JBT Marel Corporation, will also serve on the Audit and Governance & Sustainability Committees. The appointment adds a seasoned public-company CEO with a strong track record in organic and inorganic growth to the board.
- · Brian Deck is currently CEO of JBT Marel Corporation (NYSE: JBTM), a food and beverage technology solutions provider.
- · He previously served as CFO of National Material and held financial leadership roles at Ryerson, General Electric, and Bank One Corporation.
- · SPX has approximately 5,300 employees in 16 countries.
27-07-2026
XPO appointed Michael Kneeland to its board of directors, effective immediately, expanding the board to eight members, seven of whom are independent. Kneeland is non-executive chairman of United Rentals and also serves as chairman of Gildan Activewear and as a director of XPO spin-off GXO Logistics. Chairman and CEO Mario Harik highlighted Kneeland's track record of creating over $60 billion in shareholder value through operational excellence and disciplined capital allocation.
- · Kneeland joined United Rentals in 1998 and served as CEO from 2007 to 2019, including 10 concurrent years as president.
- · Kneeland became chairman of United Rentals upon his retirement in 2019.
- · XPO is an asset-based less-than-truckload (LTL) freight transportation company in North America.
- · XPO serves 55,000 customers with 594 locations and 37,000 employees in North America and Europe.
27-07-2026
Precision BioSciences announced senior leadership changes effective August 1, 2026: Alex Kelly promoted from CFO to COO, and Naresh Tanna promoted from VP of IR and Chief of Staff to CFO. The company also hired two new physician leaders under Chief Development Officer Cindy Atwell to support clinical programs PBGENE-HBV and PBGENE-DMD. These changes aim to support advancement through next clinical milestones.
- · Leadership changes effective August 1, 2026.
- · Alex Kelly promoted from CFO to newly created COO role.
- · Naresh Tanna promoted from VP of IR and Chief of Staff to CFO.
- · Two new physician leaders hired under Cindy Atwell.
- · Cassie Gorsuch now leads all research functions including translational sciences.
27-07-2026
International Battery Metals announced the appointment of Garrett Galloway, Senior Vice President of Corporate Development, as Interim CEO, effective immediately, following the resignation of Joseph Mills as CEO and from the Board of Directors. Mills resigned to spend time with family and pursue other opportunities, and will remain in an advisory role through September 19, 2026. The company continues to pursue project opportunities in the Smackover, Middle East, North America, and South America, with priorities and initiatives unchanged.
- · Garrett Galloway has over 15 years of experience in the energy industry including finance, M&A, and capital markets.
- · Galloway previously served as Vice President of Finance at QuarterNorth Energy and played a key role in its divestiture to Talos Energy, returning approximately $1.9 billion to shareholders.
- · Galloway holds a bachelor's degree in business and finance from the University of Alabama.
- · Joseph Mills' resignation was effective July 21, 2026, and he will remain available through September 19, 2026 for transition assistance.
- · The company's focus remains on advancing extraction of lithium chloride from ground water salt brine and produced water deposits.
27-07-2026
Generation Income Properties, Inc. entered into a Debt Conversion Agreement on July 24, 2026, converting $120,000 of outstanding debt owed to the David E. Sobelman Revocable Trust into 162,163 shares of common stock at $0.74 per share. The conversion, combined with a prior preferred equity amendment, brought the company's stockholders' equity above $5 million, helping address Nasdaq compliance. However, Nasdaq will continue to monitor compliance, and failure to evidence compliance at the next periodic report could lead to delisting.
- · The conversion price was $0.74 per share, based on the Nasdaq Official Closing Price on July 23, 2026.
- · The shares were issued in reliance on exemptions from registration under Section 4(a)(2) and Rule 506 of Regulation D, based on the trust being an Accredited Investor.
- · The company remains subject to ongoing Nasdaq monitoring of the Stockholders' Equity Requirement and may face delisting if compliance is not evidenced at the next periodic report.
27-07-2026
Kustom Entertainment (Nasdaq: KUST) announced an amendment to its divestiture agreement with Cycurion (Nasdaq: CYCU), increasing the total valuation to $6.1M and replacing 2,000,000 warrants with high-yield Series H Preferred Stock featuring a 12% annual cumulative dividend. The deal includes an immediate $250,000 non-refundable cash payment and extends the closing target to September 15, 2026. The company has completed its transformation into a pure-play live entertainment company. The filing is about KUST, not DGLY.
- · Amendment executed on July 23, 2026.
- · All conditions precedent under original agreement fully satisfied or waived.
- · Series H Preferred Stock carries senior liquidation preferences, class voting protections, and registration rights.
- · Dividend paid quarterly in shares of Cycurion common stock.
- · Company's flagship event Country Stampede celebrated its 30th Anniversary in June 2026.
- · Festival expansion to Gilley’s Park City (Wichita metro area) doubles capacity to 35,000 fans per show.
27-07-2026
Cracker Barrel announced a CEO succession: David Deno will become CEO and join the Board effective August 10, 2026, succeeding Julie Masino, who will step down as CEO and director but remain in an advisory capacity through October 9, 2026. The filing contains no financial results or period-over-period comparisons, so no quantitative performance data is available.
- · David Deno previously served as CEO of Bloomin' Brands from 2019 to 2024 and as its CFO from 2012 to 2019, leading the company through its IPO.
- · Deno also held senior roles at Best Buy (President of Asia and CFO of International Division) and spent 15 years at Yum! Brands and Pizza Hut.
- · Deno currently serves on the boards of Krispy Kreme, Inc. and Panera Brands.
- · Cracker Barrel operates approximately 660 company-owned stores in 43 states.
27-07-2026
Novelis Inc. entered into a $500 million short-term unsecured term loan facility on July 23, 2026, borrowed in full on July 24, 2026, for general corporate purposes. The facility matures in 24 months, bears interest at Term SOFR plus 1.00% (or 1.25% if credit rating falls), and includes customary covenants and a cross-default provision for indebtedness over $100 million. No period-over-period comparisons are available as this is a one-time financing event.
- · The facility is unsecured and guaranteed by Novelis Inc.
- · No amortization payments are required; maturity is 24 months from first utilization (July 24, 2026).
- · Voluntary prepayment is allowed only after September 21, 2026, and amounts repaid cannot be reborrowed.
- · Negative covenants restrict mergers, acquisitions, investments, additional indebtedness, restricted payments, affiliate transactions, and prepayment of certain debt.
- · The cross-default provision applies to any other indebtedness with aggregate principal over $100 million.
27-07-2026
AB Commercial Real Estate Private Debt Fund, LLC, through its borrower subsidiary AB CRE PDF TNVA1 LLC, amended its existing loan agreement with HSBC Bank USA, N.A. to increase the total loan facility from $147.7M to $188.6M, adding a $40.9M additional loan secured by a mortgage on a Walsh Ranch development property. The amendment extends the initial maturity date to June 9, 2028, and includes updated guaranties and servicing acknowledgments. No defaults or material adverse changes were reported, and the borrower and guarantor released HSBC and lenders from prior claims.
- · The amendment was effective July 23, 2026, and filed as an 8-K on July 27, 2026.
- · The additional loan is secured by a $58.4M mortgage loan made by AB Commercial Real Estate Private Debt Fund, LLC to Walsh Ranch Development Owner LP.
- · The initial maturity date was extended to June 9, 2028.
- · The borrower and guarantor released HSBC and lenders from all claims arising prior to the effective date, except for future breaches, gross negligence, willful misconduct, or bad faith.
- · No default or event of default existed before or after giving effect to the amendment.
27-07-2026
PetVivo Holdings, Inc. disclosed that its independent auditor, Stephano Slack LLC, resigned effective July 2, 2026, and the company engaged GuzmanGray as its new independent registered public accounting firm on July 23, 2026. The resignation was triggered by a reportable event: Stephano Slack's audit report for the fiscal year ended March 31, 2026 included an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern. No other disagreements or reportable events occurred during the relevant periods.
- · Stephano Slack's reports for fiscal years ended March 31, 2026 and March 31, 2025 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.
- · During the fiscal years ended March 31, 2026 and March 31, 2025 and the subsequent interim period through July 23, 2026, there were no disagreements between the company and Stephano Slack on any matter of accounting principles or practices.
- · The only reportable event was the going concern explanatory paragraph in the FY2026 audit report.
- · GuzmanGray was engaged for the fiscal year ending March 31, 2027, including interim review periods ending June 30, 2026, September 30, 2026 and December 31, 2026.
- · Neither the company nor anyone on its behalf had consulted with GuzmanGray regarding accounting principles, disagreements, or reportable events prior to engagement.
27-07-2026
Independent Bank Corporation appointed Nathan E. Tagg to its Board of Directors effective July 21, 2026, following the acquisition of HCB Financial Corp. and Highpoint Community Bank on July 1, 2026. Mr. Tagg, an attorney and former Highpoint board member, will also serve on the Audit Committee. The filing is a routine board appointment with no financial impact or negative developments.
- · Full system integration of Highpoint Community Bank's operations expected on November 9, 2026.
- · Mr. Tagg earned his Juris Doctor from Howard University School of Law.
- · Independent Bank was founded in 1864 as First National Bank of Ionia.
27-07-2026
Power Solutions International, Inc. (PSIX) appointed Richard Hu as Chief Executive Officer, effective August 17, 2026, following a comprehensive executive search by Spencer Stuart. Hu, a veteran global industrial executive with over 25 years of experience, most recently served as VP and GM of the Americas Region for BorgWarner's Turbo & Thermal Technology business unit. He succeeds Xun (Kenneth) Li, who had served as Interim CEO since May 2026 and will remain as CFO.
- · Hu's appointment is effective August 17, 2026.
- · Hu was identified through a comprehensive executive search conducted by Spencer Stuart.
- · Hu spent six years at BorgWarner from 2020 to 2026, most recently as VP and GM of the Americas Region for the Turbo & Thermal Technology business unit.
- · Hu previously served as SVP and GM of Delphi Technologies' Global Powertrain business unit, helping navigate its acquisition by BorgWarner in 2020.
- · Hu's career also includes senior roles at Eberspächer, Magna Steyr, and Magneti Marelli.
- · The Board emphasized Hu's ability to drive profitable growth, particularly in the data center market.
- · The filing includes cautionary notes about forward-looking statements and risks related to leadership transitions.
27-07-2026
SmartKem, Inc. filed an 8-K on July 27, 2026, disclosing the issuance of a Convertible Promissory Note by Ferrox Critical Minerals to SmartKem, and reporting that as of that date there were 25,862,643 shares of common stock outstanding. The filing is primarily a routine disclosure of a material agreement and share count, with no financial results or performance metrics provided.
- · The Convertible Promissory Note was issued by Ferrox Critical Minerals to SmartKem, Inc. on July 27, 2026.
- · The filing includes items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 8.01 (Other Events).
27-07-2026
Gossamer Bio announced a planned NDA submission for seralutinib in PAH in September 2026 following a productive Pre-NDA Type B meeting with the FDA, and reacquired worldwide rights to seralutinib from Chiesi without upfront cash, receiving a $5 million payment from Chiesi. The company also completed a convertible note exchange that reduced debt by approximately $115.9 million and stockholders approved a reverse stock split authorization. However, the company reported preliminary cash, cash equivalents and marketable securities of only approximately $57 million as of June 30, 2026, which may be insufficient to fund operations through a potential approval decision in Q3 2027 without additional capital.
- · FDA characterized the degree of statistical significance and magnitude of treatment effect in PROSERA as review issues, not filing issues.
- · NDA submission planned for September 2026; if accepted, potential FDA approval decision in Q3 2027.
- · Termination of Chiesi agreement dissolves prior U.S. 50/50 profit share and returns ex-U.S. rights to Gossamer.
- · Chiesi is entitled to a capped royalty on worldwide net sales of seralutinib and payments upon achievement of specified regulatory and commercial milestones.
- · Reverse stock split expected to be effected in or promptly following Q3 2026, subject to final Board action.
- · Cash position of $57M may require additional financing to reach potential approval in Q3 2027.
27-07-2026
Kymera Therapeutics announced the appointment of Terence Rooney, MD, as Chief Medical Officer, effective immediately. Dr. Rooney, a former immunology leader at Johnson & Johnson, will lead global clinical development strategy across Kymera's oral immunology portfolio. He succeeds Jared Gollob, MD, who is retiring after eight years with the company and will remain as an advisor through year-end.
- · Dr. Rooney previously served as Senior Vice President, Portfolio and Asset Management Leader, Immunology, at Johnson & Johnson.
- · He has held senior leadership roles across immunology R&D at Eli Lilly and Roche.
- · His experience spans small molecules, peptides, biologics, cell therapies, combination and precision therapy strategies, and therapeutic areas including dermatology, respiratory, rheumatology, gastroenterology and rare diseases.
- · Dr. Rooney contributed to successful marketing applications for ICOTYDE®, IMAAVY®, OLUMIANT®, STELARA®, and TREMFYA®.
- · He received his medical degrees from the Royal College of Surgeons in Ireland and a doctorate from the National University of Ireland.
- · Jared Gollob will remain as an advisor through the end of the year.
27-07-2026
Lyft appointed Ben Minicucci, CEO of Alaska Air Group, to its Board of Directors as a Class II director effective July 23, 2026. Minicucci brings significant operating experience and transportation safety expertise. Lyft and Alaska have an existing partnership where Lyft paid $3.2M to Alaska and received $0.16M in 2025.
- · Minicucci will serve as a Class II director with term expiring at 2027 Annual Meeting.
- · Minicucci holds a B.S. and M.S. from Royal Military College of Canada and graduated from Harvard Business School Advanced Management Program.
- · Minicucci served in Canadian Armed Forces for 14 years.
- · Lyft and Alaska entered a partnership agreement in July 2022 allowing Lyft riders to earn Atmos Rewards miles.
- · Minicucci will receive standard non-employee director compensation as described in Lyft's April 10, 2026 Proxy Statement.
- · Lyft will enter into its standard form of indemnification agreement with Minicucci.
27-07-2026
Somnigroup International Inc. announced the successful amendment of its $2.9 billion senior secured credit facilities, comprising a $1.7 billion revolver and a $1.2 billion term loan A. The refinancing extends maturities, lowers the cost of capital, and provides an incremental $700 million of liquidity, which was used to repay a portion of its term loan B, reducing expected annual interest expense by approximately $5 million. The transaction enhances financial flexibility and positions the company for future growth.
- · The refinancing extends debt maturities and enhances financial flexibility.
- · The company utilized the incremental $700 million to repay a portion of its term loan B.
- · The transaction reflects strong support from numerous global lending partners.
27-07-2026
Translational Development Acquisition Corp. (TDAC) entered into a Subscription Agreement on July 27, 2026, with ProLogium Holding Inc. and a subscriber for the sale of securities in connection with a business combination. The subscriber, an accredited investor, will purchase ordinary shares and warrants exercisable at $11.50 per share, with proceeds expected to fund the combination. The filing notes forward-looking risks including potential delays, shareholder approval failures, and redemption requests, and the registration statement for the business combination has not yet been declared effective.
- · The Subscription Agreement was filed as Exhibit 10.1, with certain schedules omitted and confidential information redacted.
- · The subscriber is an accredited investor and institutional account, and the securities are being sold under Section 4(a)(2) of the Securities Act.
- · The registration statement on Form F-4 for the business combination has not yet been declared effective by the SEC.
- · TDAC is a blank check company, so the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 is not available.
27-07-2026
FOXO TECHNOLOGIES INC. (via its subsidiary Vector BioSource, Inc.) has entered into a definitive Asset Purchase Agreement to acquire certain blood collection centers and related assets from Grifols Bio Supplies Inc. The deal includes an upfront closing payment and an earn-out of up to $1.5M per year (2026-2028) based on EBITDA thresholds. The acquisition expands FOXO's research-use-only biospecimen business, but the filing does not disclose the total purchase price or the number of centers acquired, and the earn-out is contingent on future performance.
- · The Asset Purchase Agreement is dated July 22, 2026.
- · The acquired assets include 1,000 liters of serum and all existing cell units at the blood collection centers at closing.
- · The earn-out period covers calendar years 2026, 2027, and 2028.
- · The agreement includes standard representations, warranties, and indemnification provisions.
- · The long stop date for closing is nine months from the agreement date (April 22, 2027).
27-07-2026
Zeta Global closed a new $1 billion credit facility, refinancing its existing $550 million facility and lowering credit spreads. The facility consists of a $250 million Term Loan A and a $750 million undrawn Revolving Credit Facility, providing increased liquidity for M&A, share repurchases, and general corporate purposes. The company's CFO highlighted the strengthening of the balance sheet and enhanced financial flexibility.
- · The new facility lowers credit spreads compared to the prior $550 million facility.
- · The $750 million Revolving Credit Facility remains undrawn at closing.
- · BofA Securities served as Lead Arranger and Bookrunner; Citi, JPMorgan, RBC Capital Markets, and Truist Securities served as Joint Lead Arrangers and Joint Bookrunners.
- · Flagstar and Morgan Stanley served as Co-Documentation Agents; MUFG was a participant.
- · The company intends to use the facility for accretive M&A, share buybacks, and general corporate purposes.
27-07-2026
Target Hospitality closed a new $660 million asset-based revolving credit facility (ABL Facility), replacing its previous $175 million facility and nearly quadrupling its committed borrowing capacity. The new facility extends the maturity to July 2031, reduces borrowing costs by up to 250 basis points, and includes an accordion feature that could increase total capacity to $850 million. The company is pursuing an active commercial pipeline representing more than 20,000 beds across high-value end markets.
- · The ABL Facility has a five-year term maturing in July 2031.
- · Borrowings bear interest at Term SOFR plus 2.25% to 3.00% depending on Total Leverage Ratio.
- · The facility replaces the previous $175 million senior secured revolving credit facility.
- · The accordion feature could increase total committed borrowing capacity to $850 million.
- · The company is pursuing an active commercial pipeline representing more than 20,000 beds.
27-07-2026
Lattice Semiconductor completed its acquisition of AMI on July 27, 2026, creating what it describes as the industry's most complete secure management and control platform for data center AI and physical AI. The deal is expected to be accretive to gross margin, free cash flow, and non-GAAP EPS, and supports Lattice's trajectory toward a $1 billion or greater annual revenue run rate by end of 2026. AMI will operate as a dedicated, silicon-neutral business unit under its existing leadership, preserving its open approach to platform firmware.
- · Acquisition was first announced on May 4, 2026.
- · Lattice expects to provide additional information on AMI’s operating results and anticipated future performance when it reports its second quarter 2026 results on August 4, 2026.
- · The AMI business unit will continue to be led by long-time AMI CEO Sanjoy Maity, reporting directly to CEO Ford Tamer.
- · AMI's firmware and manageability solutions will continue to be developed and delivered without preference for any silicon vendor, including Lattice.
27-07-2026
Glucotrack, Inc. entered into an Exchange Agreement with a lender to partition a $900,000 promissory note from an existing $3,600,000 note (previously reduced by $600,000 and $988,000 in prior exchanges) and exchange it for shares of common stock at a variable price tied to Nasdaq closing prices. The exchange is structured under Section 3(a)(9) of the Securities Act, with shares to be issued free of restrictive legends and subject to a 9.99% beneficial ownership limitation. This transaction dilutes existing shareholders and reflects ongoing debt-to-equity conversion, with no new cash proceeds to the company.
- · The Exchange Shares are issued at a variable price equal to the lower of the prior day's Nasdaq closing price or the 5-day average closing price.
- · Shares are delivered via DWAC to the lender's brokerage account within 3 business days of each exchange request.
- · The lender's beneficial ownership is capped at 9.99% of outstanding common stock after each issuance.
- · The holding period for Rule 144 purposes is tacked back to the original note issuance date of September 12, 2025.
- · No new cash consideration is received by Glucotrack; the exchange solely reduces the note principal.
- · This is the third exchange agreement involving the same original note, indicating repeated debt restructuring.
27-07-2026
The Dayton Power and Light Company (AES Ohio) dismissed Ernst & Young (EY) as its independent auditor effective upon filing its Q2 2026 10-Q, due to EY losing independence after the pending merger of parent AES with entities controlled by Global Infrastructure Management and EQT Infrastructure VI. KPMG has been engaged as the replacement auditor for fiscal year 2026. No disagreements or reportable events occurred with EY during the prior two fiscal years or the subsequent interim period.
- · EY's audit reports for fiscal years ended December 31, 2024 and 2025 were unqualified — no adverse opinion, disclaimer, or modification.
- · No disagreements (as defined by Item 304(a)(1)(iv) of Regulation S-K) or reportable events occurred between the company and EY during the covered periods.
- · The dismissal is effective upon the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
- · KPMG was engaged on July 23, 2026 for the fiscal year ending December 31, 2026.
27-07-2026
IPALCO Enterprises, Inc., a subsidiary of The AES Corporation, dismissed Ernst & Young LLP (EY) as its independent auditor and engaged KPMG LLP, effective upon filing of the Q2 2026 Form 10-Q. The change was triggered by EY losing independence under SEC rules following the announced merger of AES with entities controlled by Global Infrastructure Management and EQT Infrastructure VI. No disagreements or reportable events occurred during EY's tenure, and its audit reports for fiscal years 2024 and 2025 were unqualified.
- · Dismissal of EY and engagement of KPMG both occurred on July 23, 2026.
- · The change is effective upon filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
- · EY's audit reports for fiscal years ended December 31, 2024 and 2025 were unqualified with no adverse opinion or disclaimer.
- · No disagreements or reportable events occurred between the company and EY during fiscal years 2024, 2025, or the subsequent interim period.
- · EY provided a letter to the SEC dated July 27, 2026, filed as Exhibit 16.1, agreeing with the company's disclosures.
27-07-2026
HeartSciences Inc. entered into Amendment No. 1 to its Agreement and Plan of Merger with Fortitude Mining Holdings, Inc. and related parties, dated July 27, 2026. The amendment clarifies redemption mechanics in the LLC agreement and modifies provisions for shareholder action by written consent. This is a procedural update to the previously announced merger transaction, with no new financial figures disclosed.
- · The amendment replaces the form of A&R LLC Agreement to clarify certain redemption mechanics.
- · The amendment replaces the form of Parent New Charter to provide for a proposed amendment to the requirements for HeartSciences shareholder action by written consent.
- · The amendment also adjusts the conversion formula for Fortitude Non-Voting Units and adds a new section for certain adjustments related to reverse stock splits.
- · A special meeting of HeartSciences stockholders will be held to approve the transactions; a proxy statement will be filed with the SEC.
27-07-2026
Gabelli Multimedia Trust Inc. (GGT) entered into Amendment No. 3 to its sales agreement with G.research, LLC, allowing the Fund to sell up to 22,000,000 shares of common stock in at-the-market offerings. The minimum sale price per share will be no less than the then-current net asset value per share plus the per-share commission. The offering commenced on July 27, 2026, under an effective shelf registration statement.
- · The amendment is dated July 27, 2026, and amends the original sales agreement dated April 16, 2025.
- · The offering is made under prospectus supplement dated July 27, 2026, and accompanying prospectus dated April 19, 2024, part of shelf registration statement on Form N-2 (File No. 333-277213).
- · The opinion of Venable LLP regarding the legality of the common stock is filed as Exhibit 5.1.
27-07-2026
AES Corp. dismissed EY as its independent auditor effective upon filing of its Q2 2026 10-Q, due to EY losing independence after the closing of the pending merger with entities controlled by Global Infrastructure Management and EQT Infrastructure VI. The Audit Committee simultaneously engaged KPMG as the new auditor for FY 2026. EY's audit reports for FY 2024 and 2025 were unqualified, but its FY 2024 internal control report contained an adverse opinion due to a material weakness related to the AES Brasil disposition process.
- · EY's dismissal is effective upon the filing of the Q2 2026 10-Q.
- · EY's report on internal control over financial reporting as of December 31, 2024 contained an adverse opinion due to a material weakness in controls related to the AES Brasil disposition process.
- · No disagreements (as defined by Item 304(a)(1)(iv)) occurred between the Company and EY during FY 2024, FY 2025, or the subsequent interim period.
- · KPMG identified impermissible services (tax advisory, payroll processing, employment legal advice, financial model review) provided to certain subsidiaries during the audit period, but all such services were completed or terminated before KPMG's appointment, and KPMG concluded its independence was not impaired.
- · Neither the Company nor anyone on its behalf consulted KPMG regarding accounting principles or audit opinions during FY 2024, FY 2025, or the subsequent interim period.
27-07-2026
Talos Energy announced a farm-in agreement to acquire a 50% working interest in Block 29 offshore Mexico from Repsol. The transaction includes a contingent $30 million payment at final investment decision (FID), a cash carry of up to $20 million on the next exploration well, and reimbursement of certain pre-closing costs. The block contains the Polok and Chinwol oil discoveries with an estimated 200+ million barrels of oil equivalent (MMBoe) of gross recoverable resource, and partners expect to progress toward FID in 2027, subject to Mexican regulatory approvals.
- · Transaction is subject to approval by Mexico's Secretaría de Energía (SENER) and the National Anti-trust Commission of Mexico.
- · Block 29 is located in the Salinas-Sureste Basin in the southern Gulf of Mexico, an area with more than a dozen deepwater discoveries.
- · The development concept is based on a floating production, storage and offloading (FPSO) vessel.
- · Talos will hold a 50% working interest and, together with Repsol, will be the sole participants in the block upon closing.
- · The farm-in advances Pillar Three of Talos' strategy and complements a recently announced Gulf of America bolt-on acquisition.
27-07-2026
Addentax Group Corp. (ATXG) entered into a Loan Conversion Agreement with lender SEAH CHIA YEE on July 27, 2026, converting $699,885 in outstanding principal plus $3,500 in accrued interest into 146,539 shares of common stock at $4.80 per share. The conversion will fully satisfy and discharge the loan and all accrued interest. The shares are being issued in an offshore transaction under Regulation S exemption from registration.
- · The Conversion Shares will bear restrictive legends as required under the Securities Act.
- · The closing is subject to continued effectiveness of corporate approvals, submission of a Listing of Additional Shares notification to Nasdaq, and absence of any law or order prohibiting the transaction.
- · The lender SEAH CHIA YEE is not a 'U.S. person' under Regulation S.
27-07-2026
DPL LLC, a subsidiary of The AES Corporation, dismissed Ernst & Young LLP as its independent auditor and engaged KPMG LLP, effective upon the filing of its Q2 2026 Form 10-Q. The change is driven by EY's loss of independence following the announced merger of AES with entities controlled by Global Infrastructure Management and EQT Infrastructure VI. EY's prior audit reports for fiscal years 2024 and 2025 were unqualified, and there were no disagreements or reportable events with EY during the relevant periods.
- · The dismissal and engagement are effective upon the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
- · EY's audit reports for fiscal years ended December 31, 2024 and 2025 were unqualified and not modified as to uncertainty, audit scope, or accounting principles.
- · No disagreements or reportable events occurred between DPL and EY during fiscal years 2024, 2025, or the subsequent interim period through July 23, 2026.
- · EY provided a letter to the SEC dated July 27, 2026, agreeing with the company's disclosures, filed as Exhibit 16.1.
27-07-2026
On July 23, 2026, Isiah Lord Thomas III, the majority voting power holder and CEO of One World Products, Inc., removed Dr. Kenneth L. Perego, II from the Board of Directors effective immediately. Concurrently, the board size was reduced from seven to five directors, eliminating both the vacancy from Dr. Perego's removal and a pre-existing vacancy. This represents a significant governance change but does not include any financial metrics or period-over-period comparisons.
- · The removal was effected by written consent in lieu of a meeting under Nevada law (Sections 78.320 and 78.335).
- · The board reduction eliminated a pre-existing vacancy in addition to the vacancy from Dr. Perego's removal.
- · The authorized number of directors now equals the number of directors in office.
27-07-2026
Ocean Power Technologies (OPTT) entered into an At The Market (ATM) offering agreement with H.C. Wainwright & Co., LLC on July 27, 2026, allowing the company to sell up to $20,000,000 of its common stock through an at-the-market offering. The agreement provides OPTT with a flexible capital-raising vehicle, with Wainwright receiving a 3.00% commission on gross proceeds and reimbursement of up to $50,000 in legal expenses. The filing does not indicate any impediments or negative performance metrics, but represents a potential dilution risk for existing shareholders.
- · The ATM offering is at-the-market via Rule 415(a)(4) under the Securities Act of 1933.
- · Sales can be made through any method permitted by law, including direct sales on NYSE American or through market makers.
- · Wainwright is not obligated to purchase any shares on a principal basis unless otherwise agreed in writing.
- · The company is not obligated to make any sales under the agreement.
- · Shares are issued under the effective shelf registration statement on Form S-3 (File No. 333-275843), effective December 12, 2023.
- · A prospectus supplement dated July 27, 2026 was filed with the SEC in connection with the offering.
27-07-2026
Unity Software Inc. appointed Michael Lieb as Chief Accounting Officer and principal accounting officer, effective July 27, 2026. Mr. Lieb brings experience from Peloton, Shutterstock, Spotify, and Ernst & Young. His compensation includes a $385,000 base salary, a 40% target bonus, and a $1.2 million RSU award vesting over four years. The filing contains no negative or flat metrics, as it is a routine officer appointment.
- · RSU award vests over four years: 25% on August 25, 2027, and 6.25% quarterly thereafter.
- · Mr. Lieb holds a B.S. from Binghamton University and an M.S. from the University of Notre Dame.
- · No family relationships or material interests in transactions requiring disclosure under Item 404(a).
27-07-2026
Ameresco, Inc. announced the appointment of Brian Cox to its Board of Directors, effective July 27, 2026. Mr. Cox brings over two decades of experience in data center energy infrastructure, capital allocation, and corporate strategy, having founded and led STACK Infrastructure. This appointment is expected to support Ameresco's growth in energy infrastructure and data center power solutions.
- · Brian Cox is founder and former CEO of STACK Infrastructure, a global digital infrastructure platform.
- · Prior to STACK, Cox served as COO and CFO at Cologix, Inc. and held leadership roles at Tempo Financial Holdings and KPMG LLP.
- · Cox serves on the boards of STACK and Gigabit Fiber.
- · He holds a BBA from Texas Christian University and an MBA from the University of Colorado, and is a CPA and former U.S. Army Reserve officer.
- · Ameresco has delivered over $15 billion in solutions and contracted over 5 GW of energy resources since 2000.
27-07-2026
Co-Diagnostics, Inc. amended its equity distribution agreement with Maxim Group LLC on July 27, 2026, removing the fixed aggregate dollar limitation on sales of common stock, so future sales are now limited only by the amount of stock registered and available under its effective shelf registration statement. The company also agreed with investors from a May 2026 securities purchase agreement to extend a standstill period on new issuances and registration statements until August 14, 2026. This filing does not disclose any financial results or performance metrics, and no positive or negative financial data is provided.
- · The amendment removes the fixed aggregate dollar limitation on sales under the Original Equity Distribution Agreement.
- · Future offers and sales of common stock are limited solely by the amount of stock currently registered and available under Registration No. 333-295803.
- · The standstill period with investors from the May 19, 2026 Securities Purchase Agreement was extended to 5:00 pm Eastern Time on August 14, 2026.
- · The legal opinion of Dorsey & Whitney LLP is filed as Exhibit 5.1.
27-07-2026
Hasbro, Inc. announced the planned transition of John Hight, President of Wizards of the Coast, who will step down from that role on September 1, 2026 and serve as an Advisor to the CEO through September 2, 2027. During the advisory term, Mr. Hight will retain his $800,000 annual base salary and be eligible for a fiscal year 2026 bonus, but will not receive any 2027 bonus or additional equity grants. The filing does not disclose any successor or provide financial results, making it a routine officer transition update.
- · Transition Date: September 1, 2026
- · End Date of advisory term: September 2, 2027
- · Mr. Hight will not be eligible for any annual cash bonus for fiscal year 2027
- · No additional equity grants will be made during the advisory term
- · Outstanding long-term incentive awards will continue to vest through the earlier of the End Date or termination
- · If terminated without cause or due to death/disability, Mr. Hight will continue to receive base salary and 2026 bonus
- · If terminated voluntarily or for cause, no severance beyond accrued amounts
27-07-2026
Garrett Motion Inc. announced the appointment of Dave Crompton to its Board of Directors, effective July 27, 2026. Mr. Crompton brings over 40 years of leadership experience in commercial transportation, industrial, and energy sectors, including 28 years at Cummins Inc. The filing contains no financial results or period-over-period comparisons.
- · Garrett has six R&D centers and 13 manufacturing facilities globally.
- · The company has a 70-year history of innovation in the automotive sector and beyond.
27-07-2026
Venu Holding Corp (VENU) announced it has selected Legends Global to lead venue management at its Regent Bank Amphitheater in Broken Arrow, Oklahoma, which is targeted to open in Fall 2026. The 12,500-seat venue will have Legends handle day-to-day operations, while VENU retains sponsorship oversight and direct booking capabilities. This partnership is a positive step for VENU's venue portfolio, but the venue is not yet operational and no financial terms were disclosed.
- · VENU will continue to oversee all sponsorship agreements.
- · The venue features an open-room model and year-round programming capability.
- · VENU will book the venue directly through its internal booking team and promoter partners, including Live Nation.
- · Legends Global currently supports more than 450 venues worldwide.
- · Regent Bank Amphitheater is developed through a public-private partnership between VENU and the City of Broken Arrow.
- · The venue includes more than 230 Luxe FireSuites and the Aikman Club.
- · Strategic partners for the venue include EIGHT Elite Light Beer, Aramark Sports + Entertainment, Connect Partnership Group, Pepsi, Boingo, Tangram, Dreamseat, L-Acoustics, and Dimensional Innovations.
27-07-2026
Customers Bancorp, Inc. entered into a First Amended Employment Agreement with EVP and CFO Mark R. McCollom on July 24, 2026, which largely retains the material terms of the original June 2025 agreement. Key changes include an automatic one-year renewal mechanism, a shortened notice period (from 60 to 45 days), a release-of-claims condition for severance, continued health/dental/life insurance during severance, and a new 12-month non-compete clause. No financial figures or performance metrics are disclosed in this filing.
- · The Amended Employment Agreement supersedes the original agreement dated June 10, 2025.
- · The term automatically extends by one year on each anniversary unless either party gives 60 days' notice of cancellation.
- · The CFO's notice period for resignation was shortened from 60 to 45 days.
- · Severance compensation now requires execution of a release of claims in a form approved by the Company.
- · Health, dental, and life insurance benefits continue during the cash severance payment period.
- · A new 12-month non-compete covenant was added, covering the Company's 'Field of Interest' in defined 'Restricted Areas'.
27-07-2026
Huron Consulting Group Inc. elected Dr. L. Thomas Richards as a director effective July 23, 2026, to serve until the 2027 Annual Meeting. Dr. Richards brings extensive experience in life sciences, healthcare, and M&A, and will receive standard non-employee director compensation including a prorated annual cash retainer of $80,000 and a prorated restricted stock grant valued at $180,000 (half granted on August 1, 2026). No negative or flat metrics are present as this is a routine board appointment.
- · Dr. Richards was appointed to the Nominating and Corporate Governance Committee, Finance and Capital Allocation Committee, and Technology and Information Security Committee.
- · Dr. Richards' restricted stock grant will be prorated to half (granted August 1, 2026) and vests fully on the first anniversary.
- · Dr. Richards previously served as Chair of WittKieffer and as CEO of TessArae and interim CEO of One BioMed.
- · He practiced academic medicine as an emergency physician and assistant professor at Stanford University and UCSF.
- · He holds an M.D. from Harvard Medical School, an M.Phil. from the University of Sydney, and a B.A. from Yale University.
27-07-2026
Bed Bath & Beyond, Inc. has entered into a definitive Agreement and Plan of Merger to acquire F9 Brands, Inc. (the parent of F9 Investments, LLC) through a two-step merger process. The transaction, dated July 23, 2026, will result in F9 Brands becoming a wholly owned subsidiary of Bed Bath & Beyond. The filing does not disclose the purchase price or any financial terms of the deal.
- · The acquisition is structured as a two-step merger: first Merger Sub 1 merges into the Company, then the surviving corporation merges into Merger Sub 2, with Merger Sub 2 as the ultimate surviving entity.
- · The transaction is intended to qualify as a tax-free reorganization under Section 368(a)(1)(A) of the Internal Revenue Code.
- · Concurrent ancillary agreements include a Post-Closing Cooperation Agreement and Subscription Agreements with reinvesting employees.
- · The sole stockholder of F9 Brands has provided written consent approving the merger, eliminating the need for a stockholder vote.
- · Tom Sullivan, the indirect owner of the Seller, is party to the agreement solely for non-compete, confidentiality, and indemnification provisions.
27-07-2026
Cadiz Inc. announced the appointment of Jacinto J. Hernandez as CFO effective September 1, 2026, succeeding Stanley E. Speer who will retire after 17 years and remain as an advisor through December 31, 2026. Hernandez brings extensive capital markets and board experience from Capital Group and multiple public company boards. The company also promoted Controller Teffiny Bagnara to Vice President. No financial results or performance metrics were disclosed in this filing.
- · Stanley E. Speer served as CFO for 17 years and will continue in an advisory role through December 31, 2026.
- · Jacinto Hernandez has 26 years of career experience, including 22 years with Capital Group and its subsidiary Capital World Investors.
- · Hernandez previously served on the boards of Pioneer Natural Resources, Altria Group, Aris Water Solutions, Coterra Energy, and Devon Energy.
- · Hernandez holds a B.S. in Economics from Stanford University.
- · The RSU grant includes 200,000 fully vested upon grant and 600,000 vesting quarterly over three years.
- · PSUs vest in four tranches of 200,000 each upon achieving certain stock price hurdles within five years.
- · Cadiz owns approximately 45,000 acres of land and 220 miles of pipeline assets in California's Mojave Desert.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Material Events SEC 8-K Filings
🇺🇸 More from United States
View all →July 28, 2026
US Pre-Market SEC Filings Roundup — July 28, 2026
US Pre-Market SEC Filings Roundup
July 28, 2026
US Merger & Acquisition SEC Filings — July 28, 2026
US Merger & Acquisition SEC Filings
July 28, 2026
USA Insider Trading Pulse — July 28, 2026
USA Insider Trading Pulse
July 28, 2026
US Corporate Board Director Changes SEC Filings — July 28, 2026
US Corporate Board Director Changes SEC Filings